Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Estrogen Strength Training (BEST)
NCT00000399Phase 2Completed
- Sponsor
- University of Arizona
- Start
- Aug 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of estradiol valerate + dydrogesterone in osteoporosis (4 arms), sponsored by University of Arizona. Primary endpoint: Bone Mineral Density at 4 years. Started Aug 1995; status: completed.
02
Drugs
estradiol valerate + dydrogesterone
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00000399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000399.